[ Price : $8.95]
Federal Register notice: FDA announces the Web site location where it is posting two lists of guidance documents that CDRH intends...[ Price : $8.95]
Federal Register notice: FDA announces the revocation of an emergency use authorization issued to Janssen Biotech for the Janssen ...[ Price : $8.95]
FDA invites proposals from drug companies to participate in its fiscal year 2025 site visitation program, which is part of the age...[ Price : $8.95]
FDA posts an immediately-in-effect guidance titled Temporary Policies for Compounding Certain Parenteral Drug Products that addres...[ Price : $8.95]
FDA posts a final guidance entitled Endosseous Dental Implants and Endosseous Dental Implant Abutments Performance Criteria for S...[ Price : $8.95]
FDA approves a Pfizer BLA for Hympavzi (marstacimab-hncq) for preventing or reducing bleeding episodes in hemophilia A or B patien...[ Price : $8.95]
Sanofi discontinues a Phase 2 study evaluating the safety and efficacy of oditrasertib (SAR443820/DNL788) on serum neurofilament l...[ Price : $8.95]
Federal Register notice: FDA announces that it approved a product submission that redeemed a priority review voucher Johnson & Jo...